
Sign up to save your podcasts
Or


Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.
By John Simboli5
77 ratings
Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.

3,073 Listeners

1,983 Listeners

1,097 Listeners

2,370 Listeners

950 Listeners

800 Listeners

124 Listeners

338 Listeners

6,090 Listeners

92 Listeners

10,182 Listeners

577 Listeners

149 Listeners

249 Listeners

188 Listeners